Lupus

Aims & Scope

The only fully peer-reviewed international journal devoted exclusively to lupus (and related disease) research.

Lupus includes the most promising new clinical and laboratory-based studies from leading specialists in all lupus-related disciplines.

Invaluable reading, with extended coverage, lupus-related disciplines include: Rheumatology Dermatology Immunology Obstetrics Psychiatry Cardiovascular Research Leading international specialists present their findings on Lupus, in one outstanding reference.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	1.90

SJR (SCImago Journal Rank)

Year	Value
2024	0.779

Quartile

Year	Value
2024	Q2

h-index

Year	Value
2024	122

Journal Rank

Year	Value
2024	7032

Journal Citation Indicator

Year	Value
2024	1514

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines

  Citation: 697

  Authors: R A, R, P G, D, M-C, J-C, M A, Y

• Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden

  Citation: 623

  Authors: N, J A, M S

• Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies

  Citation: 430

  Authors: G, MJ, I, R, M, R, D, S, S, V, S, M, M

• Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies

  Citation: 378

  Authors: A A, G, L, J, G, H, L

• Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus

  Citation: 374

  Authors: C K, CY Y, EK, CWK

• Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus

  Citation: 348

  Authors: G, M-V, J-I, M, I, A, J-G, C

• Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study

  Citation: 327

  Authors: R A, V S, M J, R C, J LMB, B R, E MN, N R

• Adolescent onset of lupus results in more aggressive disease and worse outcomes: results of a nested matched case–control study within LUMINA, a multiethnic US cohort (LUMINA LVII)

  Citation: 321

  Authors: LB, AG, M, LM, G, M, BJ, HM, JD, GS

• Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity

  Citation: 315

  Authors: M, A, S, B, P, B, R H

• Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients

  Citation: 308

  Authors: Y., Y.-S., M., T.-Y., C.-X., Y.-H., Z.-M., Y.-B.

---